ID

63

Description

ODM derived from http://clinicaltrials.gov/ct2/show/record/NCT00050999

Link

http://clinicaltrials.gov/ct2/show/record/NCT00050999

Keywords

  1. 11/14/11 11/14/11 -
  2. 3/23/14 3/23/14 - Martin Dugas
  3. 4/11/14 4/11/14 - Julian Varghese
Uploaded on

November 14, 2011

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0 Legacy

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00050999 T-Cell Lymphoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion
Description

Inclusion

18 Years and older
Description

Age

Data type

boolean

Histopathologically confirmed recurrent or persistent CTCL as determined by reference pathology lab
Description

CTCL

Data type

boolean

Patient must have had 1 to 3 prior CTCL therapies. Repeated use of the same agent is considered to be 1 therapy unless it is part of a different combination regimen. Only 1 prior combination cytotoxic regimen is permitted. Topical or systemic steroids are not considered a therapy;
Description

Prior CTCL therapy

Data type

boolean

Interleukin-2 receptor (IL-2R) expression on at least 20% of tumor cells as determined by immunohistochemistry
Description

Interleukin-2 receptor expression

Data type

boolean

Stage IA - III disease and unlikely to progress during the first month on study. Life expectancy of at least 12 months. Measurable or evaluable disease. Lymph node involvement no greater than LN2. No CTCL involvement of bone marrow.
Description

Disease stage

Data type

boolean

No active CNS disease, kidney or liver disease, significant pulmonary disease, or cardiac disease. No systemic infections
Description

Other diseases

Data type

boolean

Willingness to be randomized to a placebo treatment only arm
Description

Willingness placebo

Data type

boolean

ECOG performance status 0 or 1
Description

ECOG

Data type

boolean

Exclusion
Description

Exclusion

Patients must not have previously received treatment with DAB389IL-2 or DAB486IL 2 (previous candidate compound evaluated in a clinical setting).
Description

Previous trials

Data type

boolean

Medical concepts
Description

Medical concepts

Age
Description

Age

Data type

string

Alias
UMLS CUI
C0001779
SNOMED CT 2010_0731
102518004
Diagnosis
Description

Diagnosis

Data type

string

Alias
UMLS CUI
C0011900
Lymphoma, T-Cell, Cutaneous
Description

CTCL

Data type

string

Alias
UMLS CUI
C0079773
SNOMED CT 2010_0731
28054005
MedDRA 13.1
10011677
Medication
Description

Pharmaceutical Preparations

Data type

string

Alias
UMLS CUI
C0013227
Chemotherapy
Description

Chemotherapy

Data type

string

Alias
UMLS CUI
C0392920
SNOMED CT 2010_0731
150415003
Interleukin 2 Receptor
Description

IL-2R

Data type

string

Alias
UMLS CUI
C0034819
SNOMED CT 2010_0731
112119008
LOINC Version 232
MTHU011559
Diagnostic Neoplasm Staging
Description

Tumor Staging

Data type

string

Alias
UMLS CUI
C0027646
SNOMED CT 2010_0731
254292007
LOINC Version 232
LP78422-0
Infection
Description

Infection

Data type

string

Alias
UMLS CUI
C0021311
SNOMED CT 2010_0731
257551009
MedDRA 13.1
10021789
CNS disorder
Description

CNS disease

Data type

string

Alias
UMLS CUI
C0007682
SNOMED CT 2010_0731
23853001
MedDRA 13.1
10007943
ICD-10-CM Version 2010
G96.9
Kidney Diseases
Description

Renal disease

Data type

string

Alias
UMLS CUI
C0022658
SNOMED CT 2010_0731
90708001
MedDRA 13.1
10029151
ICD-10-CM Version 2010
N18.9
Liver diseases
Description

Liver disorder

Data type

string

Alias
UMLS CUI
C0023895
SNOMED CT 2010_0731
235856003
MedDRA 13.1
10024670
ICD-10-CM Version 2010
K76.9
ICD-9-CM Version 2011
573.9
Lung diseases
Description

Pulmonary disease

Data type

string

Alias
UMLS CUI
C0024115
SNOMED CT 2010_0731
19829001
MedDRA 13.1
10025082
ICD-10-CM Version 2010
J98.4
Placebos
Description

Placebo

Data type

string

Alias
UMLS CUI
C0032042
ECOG performance status finding
Description

ECOG

Data type

string

Alias
UMLS CUI
C1828127
SNOMED CT 2010_0731
424122007
Enrollment
Description

Enrollment

Data type

string

Alias
UMLS CUI
C1516879

Similar models

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Inclusion
Age
Item
18 Years and older
boolean
CTCL
Item
Histopathologically confirmed recurrent or persistent CTCL as determined by reference pathology lab
boolean
Prior CTCL therapy
Item
Patient must have had 1 to 3 prior CTCL therapies. Repeated use of the same agent is considered to be 1 therapy unless it is part of a different combination regimen. Only 1 prior combination cytotoxic regimen is permitted. Topical or systemic steroids are not considered a therapy;
boolean
Interleukin-2 receptor expression
Item
Interleukin-2 receptor (IL-2R) expression on at least 20% of tumor cells as determined by immunohistochemistry
boolean
Disease stage
Item
Stage IA - III disease and unlikely to progress during the first month on study. Life expectancy of at least 12 months. Measurable or evaluable disease. Lymph node involvement no greater than LN2. No CTCL involvement of bone marrow.
boolean
Other diseases
Item
No active CNS disease, kidney or liver disease, significant pulmonary disease, or cardiac disease. No systemic infections
boolean
Willingness placebo
Item
Willingness to be randomized to a placebo treatment only arm
boolean
ECOG
Item
ECOG performance status 0 or 1
boolean
Item Group
Exclusion
Previous trials
Item
Patients must not have previously received treatment with DAB389IL-2 or DAB486IL 2 (previous candidate compound evaluated in a clinical setting).
boolean
Item Group
Medical concepts
Age
Item
Age
string
C0001779 (UMLS CUI)
102518004 (SNOMED CT 2010_0731)
Diagnosis
Item
Diagnosis
string
C0011900 (UMLS CUI)
CTCL
Item
Lymphoma, T-Cell, Cutaneous
string
C0079773 (UMLS CUI)
28054005 (SNOMED CT 2010_0731)
10011677 (MedDRA 13.1)
Pharmaceutical Preparations
Item
Medication
string
C0013227 (UMLS CUI)
Chemotherapy
Item
Chemotherapy
string
C0392920 (UMLS CUI)
150415003 (SNOMED CT 2010_0731)
IL-2R
Item
Interleukin 2 Receptor
string
C0034819 (UMLS CUI)
112119008 (SNOMED CT 2010_0731)
MTHU011559 (LOINC Version 232)
Tumor Staging
Item
Diagnostic Neoplasm Staging
string
C0027646 (UMLS CUI)
254292007 (SNOMED CT 2010_0731)
LP78422-0 (LOINC Version 232)
Infection
Item
Infection
string
C0021311 (UMLS CUI)
257551009 (SNOMED CT 2010_0731)
10021789 (MedDRA 13.1)
CNS disease
Item
CNS disorder
string
C0007682 (UMLS CUI)
23853001 (SNOMED CT 2010_0731)
10007943 (MedDRA 13.1)
G96.9 (ICD-10-CM Version 2010)
Renal disease
Item
Kidney Diseases
string
C0022658 (UMLS CUI)
90708001 (SNOMED CT 2010_0731)
10029151 (MedDRA 13.1)
N18.9 (ICD-10-CM Version 2010)
Liver disorder
Item
Liver diseases
string
C0023895 (UMLS CUI)
235856003 (SNOMED CT 2010_0731)
10024670 (MedDRA 13.1)
K76.9 (ICD-10-CM Version 2010)
573.9 (ICD-9-CM Version 2011)
Pulmonary disease
Item
Lung diseases
string
C0024115 (UMLS CUI)
19829001 (SNOMED CT 2010_0731)
10025082 (MedDRA 13.1)
J98.4 (ICD-10-CM Version 2010)
Placebo
Item
Placebos
string
C0032042 (UMLS CUI)
ECOG
Item
ECOG performance status finding
string
C1828127 (UMLS CUI)
424122007 (SNOMED CT 2010_0731)
Enrollment
Item
Enrollment
string
C1516879 (UMLS CUI)

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial